跳至主要内容
临床试验/NCT04317183
NCT04317183Unknown2 期

The Effect of Topical Chamomile in the Prevention of Chemotherapy-induced Oral Mucositis (a Randomized Controlled Clinical Trial)

Hams Hamed Abdelrahman1 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2019年5月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
发起方
入组人数
45
试验地点
1
主要终点
Changes in severity of oral mucositis at different time points along the study

研究概览

简要总结

the main aim of this study is to clinically assess the effectiveness of topical chamomile oral gel in the prevention of chemotherapy-induced oral mucositis.

详细描述

The study was designed as a randomized, controlled, clinical trial. patients who were undergoing to receive chemotherapy were divided into three groups: Group I: was given conventional treatment. Group II: was given topical oral gel of chamomile. Group III: was given topical oral gel of chamomile in combination with the conventional treatment.

All patients have clinically evaluated at the start of the chemotherapy and three weeks later for pain and oral mucositis severity.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who are going to receive 5-Fluoroucil (5-FU) based chemotherapy regime.
  • Males and females with an age of not less than 20 years and not exceeding 70 years.

排除标准

  • Patients suffering from any uncontrolled systemic diseases that affect integrity of the epithelium (such as diabetes, cardiovascular, liver disorder and renal dysfunction)
  • Pregnant and lactating women
  • Patients with findings of any physical or mental abnormality which would interfere with or be affected by the study procedure

研究组 & 干预措施

Chamomile topical gel

Experimental

Topical oral chamomile gel three times daily for three weeks.

Topical oral chamomile gel is prepared with the aid of Pharmacognosy and pharmaceutics departments, faculty of pharmacy, Alexandria University and mucoadhesive hydrogels (Carbopol® 970).

干预措施: chamomile topical oral gel (Drug)

conventional therapy

Active Comparator

Conventional therapy (symptomatic treatment) which included:

Miconaz oral gel BBC oral spray Oracure gel

Dose: Three times a day for three weeks

干预措施: Miconazole Topical Gel (Drug)

conventional therapy

Active Comparator

Conventional therapy (symptomatic treatment) which included:

Miconaz oral gel BBC oral spray Oracure gel

Dose: Three times a day for three weeks

干预措施: BBC oral spray (Drug)

conventional therapy

Active Comparator

Conventional therapy (symptomatic treatment) which included:

Miconaz oral gel BBC oral spray Oracure gel

Dose: Three times a day for three weeks

干预措施: Oracure gel (Drug)

combination therapy

Experimental

Topical oral chamomile gel three times daily for three weeks in combination with the symptomatic treatment

Symptomatic treatment which included:

Miconaz oral gel BBC oral spray Oracure gel

Symptomatic treatment dose: Three times a day for three weeks

干预措施: chamomile topical oral gel (Drug)

combination therapy

Experimental

Topical oral chamomile gel three times daily for three weeks in combination with the symptomatic treatment

Symptomatic treatment which included:

Miconaz oral gel BBC oral spray Oracure gel

Symptomatic treatment dose: Three times a day for three weeks

干预措施: Miconazole Topical Gel (Drug)

combination therapy

Experimental

Topical oral chamomile gel three times daily for three weeks in combination with the symptomatic treatment

Symptomatic treatment which included:

Miconaz oral gel BBC oral spray Oracure gel

Symptomatic treatment dose: Three times a day for three weeks

干预措施: BBC oral spray (Drug)

combination therapy

Experimental

Topical oral chamomile gel three times daily for three weeks in combination with the symptomatic treatment

Symptomatic treatment which included:

Miconaz oral gel BBC oral spray Oracure gel

Symptomatic treatment dose: Three times a day for three weeks

干预措施: Oracure gel (Drug)

结局指标

主要结局

Changes in severity of oral mucositis at different time points along the study

时间窗: Up to 3 weeks

Oral mucositis will be evaluated by the World Health Organization (WHO) scale which record the extent and severity of oral mucositis at the third week after the first chemotherapy session.

次要结局

  • Pain and discomfort severity at different time points along the study: Numeric Rating Scale(Up to 3 weeks)

研究者

发起方
Hams Hamed Abdelrahman
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Hams Hamed Abdelrahman

Assistant lecturer

Alexandria University

研究点 (1)

Loading locations...

相似试验